Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
cAMP encodes a member of an antimicrobial peptide family, characterized by a highly conserved N-terminal signal peptide containing a cathelin domain and a structurally variable cationic antimicrobial peptide, which is produced by extracellular proteolysis from the C-terminus. Additionally we are shipping cAMP Kits (46) and cAMP Proteins (7) and many more products for this protein.
Showing 10 out of 86 products:
Human Polyclonal cAMP Primary Antibody for WB - ABIN1536685
Tripathi, Tecle, Verma, Crouch, White, Hartshorn: The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. in The Journal of general virology 2012
Show all 2 references for ABIN1536685
Chemical Monoclonal cAMP Primary Antibody for ELISA - ABIN965742
J: [SOFMER, its topicality and its prospects]. in Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique 2008
Show all 2 references for ABIN965742
The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator.
Data indicate that endoplasmic reticulum (ER) stress increase sphingosine-1-phosphate (S1P (show MBTPS1 Antibodies)) production, in turn activating nuclear factor kappa B (NF-kappaB (show NFKB1 Antibodies))-mediated cathelicidin antimicrobial peptide (CAMP) synthesis.
Cathelicidin appears to play different roles in the development of pulmonary sarcoidosis and tuberculosis.
Neonates with congenital pneumonia had significantly higher serum cathelicidin and lower serum 25(OH)D compared to controls.
Taken together, these observations suggest that activation of human mast cells by LL-37 could be modified by TLR2 (show TLR2 Antibodies) ligands and the function of human mast cells could be switched from allergic reactions to innate immune response.
LL37, HMGB1 (show HMGB1 Antibodies) and S100A9 (show S100A9 Antibodies) are increased in serum during exacerbation in COPD (show ARCN1 Antibodies) patients
The aim of this project was to examine the functional impact of the human cathelicidin LL-37 and the mouse cathelicidin-related AMP (show APRT Antibodies) (CRAMP) on the pathogenesis of lupus and arthritis.
Chlamydial plasmid-encoded virulence factor Pgp3 neutralizes the antichlamydial activity of human cathelicidin LL-37.
palmoplantar pustulosis vesicle fluid contains the proteinase required for LL-37 processing and also may directly upregulate IL-8 (show IL8 Antibodies) in lesional keratinocytes, in turn contributing to the subsequent inflammation of PPP lesional skin
Data suggest that expression of cathelicidin and CYP24A1 (vitamin D3 24-hydroxylase (show CYP24A1 Antibodies)) is up-regulated in placental extravillous trophoblasts by vitamin D metabolites 1,23-dihydroxyvitamin D3 and 25-hydroxyvitamin D3.
overexpressed CRAMP in prostate tumor initially chemoattracts early myeloid progenitors to tumor microenvironment and mediates differentiation and polarization of early myeloid progenitors into protumorigenic M2 macrophages during PCa (show ENPP1 Antibodies) progression
The aim of this project was to examine the functional impact of the human cathelicidin LL-37 and the mouse cathelicidin-related AMP (show TMPRSS5 Antibodies) (CRAMP) on the pathogenesis of lupus and arthritis.
Cathelicidin, expressed by immune cells in the tumor microenvironment, promotes colon cancer growth through activation of the PTEN (show PTEN Antibodies)/PI3K/Akt (show AKT1 Antibodies) and Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling pathways.
pancreatic beta-cells' production is controlled by short-chain fatty acids produced by the gut (show GUSB Antibodies) microbiota, and is defective in non-obese diabetic (NOD) mice
Data indicate the role of cathelicidin-related antimicrobial peptide (CRAMP) as part of the innate immune defense against pathogens in bacterial CNS infections.
Hypoxia-inducible factor-1alpha (HIF-1alpha (show HIF1A Antibodies)), a transcription factor important for activating innate immune effectors, and the antimicrobial peptide LL-37 (CRAMP in mice) are key determinants of C. albicans colonization resistance.
Specific structural motifs in syndecan-1 (show SDC1 Antibodies) HS promote Staphylococcus aureus corneal infection by inhibiting neutrophil CRAMP.
these findings show that the production of an antimicrobial peptide Camp by adipocytes is an important element for protection against S. aureus infection of the skin
Cathelicidin-deficient (Cnlp(-/-)) mice produce much less LTB4 (show PTGR1 Antibodies) and TXB2 in vivo in response to TNF-alpha (show TNF Antibodies) compared with control mice.
observations indicate a nonredundant role for Fpr2 (show FPR2 Antibodies) and its agonist CRAMP in DC maturation in immune responses.
Characterization of single nucleotide polymorphisms (SNPs) and insertion-deletion (indel) polymorphisms within the bovine CATHL (show CTSL1 Antibodies) gene family.
This gene encodes a member of an antimicrobial peptide family, characterized by a highly conserved N-terminal signal peptide containing a cathelin domain and a structurally variable cationic antimicrobial peptide, which is produced by extracellular proteolysis from the C-terminus. The encoded protein has several functions in addition to antimicrobial activity, including cell chemotaxis, immune mediator induction and inflammatory response regulation.
cathelin-related antimicrobial peptide
, 18 kDa cationic antimicrobial protein
, neutrophil cationic antibacterial polypeptide of 11 kDa
, cathelin-like protein
, antibacterial peptide BMAP-34
, cathelicidin 7